Cited by 1,440Bone Metabolism and DiseasesOsteomyelitis and Bone Disorders ResearchRheumatoid Arthritis Research and Therapies

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

Open access

Lam, Jonathan, Takeshita, Sunao, Barker, Jane E., Kanagawa, Osami, Ross, F. Patrick, Teitelbaum, Steven L.·2000·Journal of Clinical Investigation

DOI 10.1172/jci11176PMC PMC387259

Open this paper in CoChat — free account Open PDF

Abstract

While TNF-alpha is pivotal to the pathogenesis of inflammatory osteolysis, the means by which it recruits osteoclasts and promotes bone destruction are unknown. We find that a pure population of murine osteoclast precursors fails to undergo osteoclastogenesis when treated with TNF-alpha alone. In contrast, the cytokine dramatically stimulates differentiation in macrophages primed by less than one percent of the amount of RANKL (ligand for the receptor activator of NF-kappaB) required to induce osteoclast formation. Mirroring their synergistic effects on osteoclast differentiation, TNF-alpha and RANKL markedly potentiate NF-kappaB and stress-activated protein kinase/c-Jun NH(2)-terminal kinase activity, two signaling pathways essential for osteoclastogenesis. In vivo administration of TNF-alpha prompts robust osteoclast formation in chimeric animals in which ss-galactosidase positive, TNF-responsive macrophages develop within a TNF-nonresponsive stromal environment. Thus, while TNF-alpha alone does not induce osteoclastogenesis, it does so both in vitro and in vivo by directly targeting macrophages within a stromal environment that expresses permissive levels of RANKL. Given the minuscule amount of RANKL sufficient to synergize with TNF-alpha to promote osteoclastogenesis, TNF-alpha appears to be a more convenient target in arresting inflammatory osteolysis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci11176

Cites

0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis, and regulation of bone mass and calcium metabolism.
Li, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1566 · Cited by 1,119

Flagged first, then by citations

Show all 0 references

Research works printed but not linked: 26

Lannigan, 1993, J Laryngol Otol, 107, 12, 10.1017/S0022215100122005 · DOI
Baroukh, 1991, J Periodontal Res, 26, 161, 10.1111/j.1600-0765.1991.tb01640.x · DOI
Nair, 1996, Infect Immun, 64, 2371, 10.1128/IAI.64.7.2371-2380.1996 · DOI
Bom-van Noorloos, 1990, J Clin Periodontol, 17, 409, 10.1111/j.1600-051X.1990.tb02338.x · DOI
Birkedal-Hansen, 1993, J Periodontal Res, 28, 500, 10.1111/j.1600-0765.1993.tb02113.x · DOI
Abu-Amer, 1997, J Clin Invest, 100, 1557, 10.1172/JCI119679 · DOI
Abu-Amer, 1998, J Biol Chem, 273, 29417, 10.1074/jbc.273.45.29417 · DOI
Teitelbaum, 2000, Science, 289, 1504, 10.1126/science.289.5484.1504 · DOI · Paper page
Quinn, 2000, J Bone Miner Res, 15, 1459, 10.1359/jbmr.2000.15.8.1459 · DOI
Ross, 2000, J Clin Invest, 105, 555, 10.1172/JCI9557 · DOI
Kobayashi, 2000, J Exp Med, 191, 275, 10.1084/jem.191.2.275 · DOI
Azuma, 2000, J Biol Chem, 275, 4858, 10.1074/jbc.275.7.4858 · DOI · Paper page
McHugh, 2000, J Clin Invest, 105, 433, 10.1172/JCI8905 · DOI
Sudo, 1995, Oncogene, 11, 2469
Beutler, 1987, Lymphokines, 14, 203, 10.1016/B978-0-12-432014-7.50012-7 · DOI
Ledgerwood, 1999, Lab Invest, 79, 1041
Siwik, 2000, Circ Res, 86, 1259, 10.1161/01.RES.86.12.1259 · DOI
Hofbauer, 1999, Bone, 25, 255, 10.1016/S8756-3282(99)00162-3 · DOI
Horwood, 1998, Endocrinology, 139, 4743, 10.1210/endo.139.11.6433 · DOI
Kitazawa, 1994, J Clin Invest, 94, 2397, 10.1172/JCI117606 · DOI
Thomson, 1987, J Immunol, 138, 775, 10.4049/jimmunol.138.3.775 · DOI
Lerner, 1993, J Bone Miner Res, 8, 147, 10.1002/jbmr.5650080205 · DOI
van der Pluijm, 1991, Endocrinology, 129, 1596, 10.1210/endo-129-3-1596 · DOI
Simonet, 1997, Cell, 89, 309, 10.1016/S0092-8674(00)80209-3 · DOI · Paper page
Iotsova, 1997, Nat Med, 11, 1285, 10.1038/nm1197-1285 · DOI
Grigoriadis, 1994, Science, 266, 443, 10.1126/science.7939685 · DOI

Sorted by citations

Items 401–500 of 1,004

Mechanisms Involved in Childhood Obesity-Related Bone Fragility
Faienza, M. F., D’Amato, G., Chiarito, M., Colaianni, G., Colucci, S. C., Grano, M., Corbo, F., & Brunetti, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00269 · Cited by 67
“Otherwise, TNFα promoted osteoclastogenesis only in the presence of RANKL permissive levels (196).”
Background
Periarticular Bone Loss in Arthritis Is Induced by Autoantibodies Against Citrullinated Vimentin
Engdahl, C., Bang, H., Dietel, K., Lang, S. C., Steffen, U., & Schett, G. A. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3158 · Cited by 59
Is Bone Loss Linked to Chronic Inflammation in Antiretroviral-Naïve HIV-Infected Adults? A 48 Week Matched Cohort Study
Hileman, C. O., Labbato, D., Storer, N., Tangpricha, V., & McComsey, G. (2014) · AIDS (London) · doi:10.1097/qad.0000000000000320 · Cited by 63
“[28] Further, tumor necrosis factor α and IL-6, inflammatory cytokines known to be elevated in both ART-treated and untreated-HIV-infected individuals compared to uninfected controls,[29, 30] both promote osteoclast formation.[31-33] In this study, given the suggestion that systemic inflammation contributes to the ris…”
Background
Effects of anti-tumor necrosis factor α agents on bone
Kawai, V. K., Stein, C., Perrien, D. S., & Griffin, M. R. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328356d212 · Cited by 70
“Activation of the NF-kb pathway by RANK/RANKL signaling is a key driver of osteoclastogenesis and bone formation.”
BackgroundInfluential
Osteoclastogenesis and arthritis
Maruotti, N., Grano, M., Colucci, S. C., Donofrıo, F., & Cantatore, F. P. (2010) · Clinical and Experimental Medicine · doi:10.1007/s10238-010-0117-2 · Cited by 61
“TNF-a and RANKL influence each other in osteoclast activation [27].”
Background
TSG‐6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin
Mahoney, D. J., Swales, C. E., Athanasou, N. A., Bombardieri, M., Pitzalis, C., Kliskey, K., Sharif, M., Day, A. J., Milner, C. M., & Sabokbar, A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30201 · Cited by 53
“RANKL by osteoblasts (38) and synovial fibroblasts (39), while IL-1 (40), IL-6 (32), and TNF (31,41,42) have been reported to stimulate osteoclast formation and induce resorptive activity directly.”
Background
Stimulation by TLR5 Modulates Osteoclast Differentiation through STAT1/IFN-β
Ha, H., Lee, J.-H., Kim, H., Kwak, H. B., Kim, H., Lee, S. E., Rhee, J. H., Kim, H., & Lee, Z. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1382 · Cited by 60
“In addition, a previous report showed that the effects of TLRs and TNF- on osteoclastogenesis are differently regulated, depending on osteoclast precursors in the bone marrow and extramedullary organs (49).”
BackgroundInfluential
Implant wear induces inflammation, but not osteoclastic bone resorption, in RANK–/– mice
Ren, W., Wu, B., Peng, X., Hua, J., Hao, H.-N., & Wooley, P. (2006) · Journal of Orthopaedic Research · doi:10.1002/jor.20190 · Cited by 63
“Interpretation of their results was questioned, because previous studies have shown the importance of RANKL/RANK signaling for osteoclastogenesis in RANK / mice.6,8 Lam et al.30 demonstrated thatwhen pure populations ofmononuclear phagocytes were isolated directly from murine bonemarrowby immunopurification, these cel…”
Background
The influence of alumina and ultra-high molecular weight polyethylene particles on osteoblast-osteoclast cooperation.
Granchi, D., Ciapetti, G., Amato, I., Pagani, S., Cenni, E., Savarino, L., Avnet, S., Peris, J. L., Pellacani, A., Baldini, N., et al. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.10.100 · Cited by 63
The Role of Substance P in the Regulation of Bone and Cartilage Metabolic Activity
Li, F., Xu, F., Lin, X., Wu, F., Zhong, J.-Y., Wang, Y., Guo, B., Zheng, M.-H., Shan, S., & Yuan, L.-Q. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00077 · Cited by 62
“SP appears to enhance RANKLinduced osteoclastogenesis and bone resorption in the same manner as tumor necrosis factor-a (TNF-a) (37).”
Background
Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases
Sabokbar, A., Mahoney, D. J., Hemingway, F., & Athanasou, N. A. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8523-6 · Cited by 61
IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells
Mccoy, E., Hong, H.-X., Pruitt, H., & Feng, X. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-16 · Cited by 62
“We and others have demonstrated that while IL-1 and TNF-α cannot promote osteoclastogenesis in the absence of RANKL, they can do so with suboptimal levels of RANKL or from RANKL-pretreated BMMs [21-26].”
Background
Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis
Jules, J., Ashley, J. W., & Feng, X. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.511179 · Cited by 58
“TNF/IL-1induced osteoclastogenesis requires priming of bone marrow macrophages (BMMs) by RANKL [87,88].”
Background
A Triterpene Glycoside from Black Cohosh that Inhibits Osteoclastogenesis by Modulating RANKL and TNFα Signaling Pathways
Qiu, S. X., Dan, C., Ding, L., Peng, S., Chen, S., Farnsworth, N. R., Nolta, J. A., Gross, M. L., & Zhou, P. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.06.010 · Cited by 61
The role of microRNA in periodontal tissue: A review of the literature
Irwandi, R. A., & Vacharaksa, A. (2016) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2016.08.014 · Cited by 72
Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity
Attia, E. A. S., Khafagy, A. H., Abdel-Raheem, S. M., Ahmed, S. F., & Saad, A. A. (2010) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2010.04600.x · Cited by 70
Mechanisms of bone loss in rheumatoid arthritis
Findlay, D. M., & Haynes, D. R. (2005) · Modern Rheumatology · doi:10.1007/s10165-005-0412-z · Cited by 56
Arthroplasty membrane‐derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening
Sabokbar, A., Itonaga, I., Sun, S.-G., Kudo, O., & Athanasou, N. (2005) · Journal of Orthopaedic Research · doi:10.1016/j.orthres.2004.10.006 · Cited by 61
Mechanisms of Osteoclastogenesis in Orthodontic Tooth Movement and Orthodontically Induced Tooth Root Resorption
Nakai, Y., Praneetpong, N., Ono, W., & Ono, N. (2023) · Journal of Bone Metabolism · doi:10.11005/jbm.2023.30.4.297 · Cited by 66
“[53-55] Also, TNF-α stimulates RANK expression in osteo-clast precursor cells.”
Background
Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases
Soos, B., Szentpetery, A., Raterman, H., Lems, W., Bhattoa, H., & Szekanecz, Z. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00764-w · Cited by 60
IL-33 Inhibits TNF-α-Induced Osteoclastogenesis and Bone Resorption
Ohori, F., Kitaura, H., Ogawa, S., Shen, W.-R., Qi, J., Noguchi, T., Marahleh, A., Nara, Y., Pramusita, A., & Mizoguchi, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031130 · Cited by 69
The impact of the intestinal microbiome on bone health
Zhang, J., Lu, Y., Wang, Y., Ren, X., & Han, J. (2018) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2018.01055 · Cited by 67
Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis
Lo, C. H., & Lynch, C. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00247 · Cited by 61
TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression
Zhao, Z., Hou, X., Yin, X., Li, Y., Duan, R., Boyce, B. F., & Yao, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135728 · Cited by 60
“However, TNF also promotes RANKL expression by osteoblastic and other cells to enhance OC formation [20, 21].”
Background
Tumor necrosis factor–inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor–driven model of rheumatoid arthritis
Binder, N. B., Puchner, A., Niederreiter, B., Hayer, S., Leiss, H., Blüml, S., Kreindl, R., Smolen, J. S., & Redlich, K. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37797 · Cited by 55
Local Regulators of Bone: IL-1, TNF, Lymphotoxin, Interferon-γ, IL-8, IL-10, IL-4, the LIF/IL-6 Family, and Additional Cytokines
Horowitz, M., & Lorenzo, J. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50155-4 · Cited by 60
Plasma cells promote osteoclastogenesis and periarticular bone loss in autoimmune arthritis
Komatsu, N., Win, S. J., Yan, M., Huynh, N. C., Sawa, S., Tsukasaki, M., Terashima, A., Pluemsakunthai, W., Kollias, G., Nakashima, T., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143060 · Cited by 61
“However, TNF can also upregulate RANKL expression in stromal cells that contaminate osteoclast precursor cell cultures, which often hampers the interpretation of the results (3, 23).”
Background
Effects of targeted therapies on the bone in arthritides.
Szentpetery, A., Horváth, Á., Gulyás, K., Pethő, Z., Bhattoa, H., Szántó, S., Szücs, G., FitzGerald, O., Schett, G., & Szekanecz, Z. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.01.014 · Cited by 59
Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates
Romas, E. (2005) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2005.06.008 · Cited by 58
Effects of polyethylene and TiAIV wear particles on expression of RANK, RANKL and OPG mRNA
Baumann, B., Rader, C., Seufert, J., Nöth, U., Rolf, O., Eulert, J., & Jakob, F. (2004) · Acta Orthopaedica Scandinavica · doi:10.1080/00016470410001222 · Cited by 59
“However, Lam et al. (2000) have shown that TNFα induction of osteoclastogenesis occurs as a result of direct stimulation of macrophages that are exposed to a stromal enviroment expressing permissive levels of RANKL.”
Background
SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters
Qiao, W., Lau, H. E., Xie, H., Poon, V. K., Chan, C. C., Chu, H., Yuan, S., Yuen, T. T., Chik, K. K., Tsang, J. O., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30195-w · Cited by 62
Titanium Particle-Challenged Osteoblasts Promote Osteoclastogenesis and Osteolysis in a Murine Model of Periprosthestic Osteolysis
Jiang, Y., Jia, T., Gong, W., Wooley, P., & Yang, S.-Y. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.03.010 · Cited by 58
“It has been shown that IL-1 and TNF-a are potent mediators of bone resorption, activating osteoclast or precursor cells by direct stimulation of macrophages and providing activation signals to lymphocytes [31].”
Background
Regulation of Sealing Ring Formation by L-plastin and Cortactin in Osteoclasts
Ma, T., Sadashivaiah, K., & Chellaiah, M. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.099697 · Cited by 68
Lipopolysaccharide-Induced Osteoclastogenesis from Mononuclear Precursors: A Mechanism for Osteolysis in Chronic Otitis
Nason, R., Jung, J. Y., & Chole, R. A. (2009) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-008-0153-8 · Cited by 60
Joint remodelling in inflammatory disease
Schett, G. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.078972 · Cited by 56
Inhibition of IKK activation, through sequestering NEMO, blocks PMMA‐induced osteoclastogenesis and calvarial inflammatory osteolysis
Clohisy, J., Yamanaka, Y., Faccio, R., & Abu-Amer, Y. (2006) · Journal of Orthopaedic Research · doi:10.1002/jor.20184 · Cited by 58
“This is not unexpected, considering that TNF family members, especially RANKL, are prerequisite for osteoclast formation.(12,13) The primary signal transduction event elicited by RANKL and TNF in various cell types including osteoclasts leads to activation of NF-kB family.”
Background
Bone Resorption in Chronic Otitis media: The Role of the Osteoclast
Jung, J. Y., & Chole, R. A. (2002) · ORL · doi:10.1159/000057787 · Cited by 53
SH3BP2 Cherubism Mutation Potentiates TNF-α–Induced Osteoclastogenesis via NFATc1 and TNF-α–Mediated Inflammatory Bone Loss
Mukai, T., Ishida, S., Ishikawa, R., Yoshitaka, T., Kittaka, M., Gallant, R., Lin, Y., Rottapel, R. K., Brotto, M., Reichenberger, E., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2295 · Cited by 64
“Although many advances have been made toward understanding the pathogenesis of inflammatory bone diseases and the role of TNF‐a in pathological bone resorptionbyosteoclasts,((24,27,28,31,32))”
Background
TNFα and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics
Dai, J. C., He, P., Chen, X., & Greenfield, E. M. (2005) · Bone · doi:10.1016/j.bone.2005.10.007 · Cited by 51
New insights into the pathophysiology and management of bone disease in multiple myeloma
Terpos, E., Politou, M., & Rahemtulla, A. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04712.x · Cited by 55
“The effects of TNF-a are mediated by stimulation of the proteolytic breakdown of I-jB, which is the inhibitor of nuclear factor-kappa B (NF-jB), leading to NF-jB activation (Lam et al, 2000).”
Background
Cytokine mRNA expression patterns in the disease course of female adolescents with anorexia nervosa.
Kahl, K., Kruse, N., Rieckmann, P., & Schmidt, M. (2004) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00131-2 · Cited by 57
“Furthermore, TNF-α has been associated with bone loss which is a severe problem in AN (Maugars et al., 1996; Castro et al., 2000; Lam et al., 2000).”
Background
Molecular Basis beyond Interrelated Bone Resorption/Regeneration in Periodontal Diseases: A Concise Review
Sadek, K. M., Moshy, S. E., Radwan, I. A., Rady, D., Abbass, M. M. S., El‐Rashidy, A. A., Dörfer, C. E., & El‐Sayed, K. M. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054599 · Cited by 64
Staphylococcus aureus protein A enhances osteoclastogenesis via TNFR1 and EGFR signaling
Bertelli, A. M., Delpino, M. V., Lattar, S. M., Giai, C., Llana, M. N., Sanjuan, N. A., Cassat, J. E., Sordelli, D. O., & Gómez, M. I. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.016 · Cited by 55
“Considering that TNF-α signaling and EGFR/RANKL crosstalk contribute to osteoclast differentiation [21,22] we postulate that protein A may induce increased osteoclastogenesis and positively modulate bone resorption during S.”
CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway
Li, C.-H., Xu, L.-L., Zhao, J.-X., Sun, L., Yao, Z.-Q., Deng, X.-L., Liu, R., Yang, L., Xing, R., & Liu, X.-Y. (2016) · Inflammation Research · doi:10.1007/s00011-015-0905-y · Cited by 56
“Patients with RA have elevated serum levels of CXCL16, and anti-TNF-a antibody therapy has been shown to reduce CXCL16 levels [22].”
Chondroitin sulfate and sulfated hyaluronan‐containing collagen coatings of titanium implants influence peri‐implant bone formation in a minipig model
Korn, P., Schulz, M. C., Hintze, V., Range, U., Mai, R., Eckelt, U., Schnabelrauch, M., Möller, S., Becher, J., Scharnweber, D., et al. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34913 · Cited by 58
Anti IL‐17A therapy inhibits bone loss in TNF‐α‐mediated murine arthritis by modulation of the T‐cell balance
Zwerina, K., Koenders, M. I., Hueber, A. J., Marijnissen, R. J., Baum, W., Ruiz‐Heiland, G., Zaiss, M. M., Mclnnes, I., Joosten, L. A. B., van den Berg, W., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141871 · Cited by 54
Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis
Chao, C., Chen, S., Adamopoulos, I. E., Davis, N. M., Hong, K., Vu, A., Kwan, S., Fayadat‐Dilman, L., Asio, A., & Bowman, E. P. (2010) · Autoimmunity · doi:10.3109/08916934.2010.517815 · Cited by 55
Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
Balga, R., Wetterwald, A., Portenier, J., Dolder, S., Mueller, C., & Hofstetter, W. (2006) · Bone · doi:10.1016/j.bone.2006.02.056 · Cited by 56
“Previously, TNFα was described to stimulate the development of osteoclasts from hematopoietic precursor cells [36].”
BackgroundInfluential
Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis
Zhao, Y., Ning, J., Teng, H., Deng, Y., Sheldon, M., Shi, L., Martinez, C., Zhang, J., Tian, A., Sun, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46602-3 · Cited by 69
“TNF-α , on the other hand, can induce osteoclast differentiation in both RANKL-dependent and RANKL-independent manners 34,35 .”
Background
Titanium surface with nanospikes tunes macrophage polarization to produce inhibitory factors for osteoclastogenesis through nanotopographic cues
Kartikasari, N., Yamada, M., Watanabe, J., Tiskratok, W., He, X., Kamano, Y., & Egusa, H. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.10.019 · Cited by 65
Odanacatib, A Cathepsin K‐Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal Diseases
Hao, L., Chen, J., Zhu, Z. G., Reddy, M. S., Mountz, J. D., Chen, W., & Li, Y. (2015) · Journal of Periodontology · doi:10.1902/jop.2015.140643 · Cited by 56
Modulatory Effect of 1,25-Dihydroxyvitamin D 3 on IL1 β -Induced RANKL, OPG, TNF α , and IL-6 Expression in Human Rheumatoid Synoviocyte MH7A
Feng, X., Lv, C., Wang, F., Gan, K., Zhang, M., & Tan, W. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/160123 · Cited by 54
Exposure to Urban Air Pollution and Bone Health in Clinically Healthy Six-year-old Children
Calderón-Garcidueñas, L., Mora-Tiscareño, A., Francolira, M., Torres-Jardón, R., Peña-Cruz, B., Palacios-López, C., Zhu, H.-T., Kong, L., Mendoza-Mendoza, N., Montesinoscorrea, H., et al. (2013) · Arhiv za Higijenu Rada i Toksikologiju · doi:10.2478/10004-1254-64-2013-2219 · Cited by 55
“TNF α and RANKL interact to potentiate two osteoclastogenic pathways: NFκB and the stress activated protein kinase/c-Jun NH2-terminal kinase activity (36).”
Small molecule inhibitors of IκB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy‐induced bone loss in vivo
Idris, A. I., Krishnan, M., Šimić, P., Landao‐Bassonga, E., Mollat, P., Vukičević, S., & Ralston, S. H. (2010) · The FASEB Journal · doi:10.1096/fj.10-164095 · Cited by 51
“Other proinflammatory cytokines such as IL1 and TNF- that also cause activation of NF B signaling have been shown to act synergistically with RANKL to enhance osteoclast formation (27), and under certain experimental circumstances, TNF- and IL1 can stimulate osteoclast formation in the absence of RANKL(28, 29).”
Background
Mechanisms modulating inflammatory osteolysis: A review with insights into therapeutic targets
Shi, W., & Siegal, G. P. (2008) · Pathology - Research and Practice · doi:10.1016/j.prp.2008.07.002 · Cited by 47
“[42] Although others argue that the inflammatory cytokine is capable of osteoclastogenesis in the absence of RANK signaling in vitro, [43] TNF-α fails to induce meaningful osteoclastogenesis in RANK deficient mice.”
Background
An Anti-c-Fms Antibody Inhibits Orthodontic Tooth Movement
Kitaura, H., Yoshimatsu, M., Fujimura, Y., Eguchi, T., Kohara, H., Yamaguchi, A., & Yoshida, N. (2008) · Journal of Dental Research · doi:10.1177/154405910808700405 · Cited by 60
“The formation of osteoclasts is dependent on macrophage-colony-stimulating factor (M-CSF) and the ligand for the receptor activator of necrosis factor B (RANKL).”
BackgroundInfluential
Erosive arthritis
Schett, G. A. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2166 · Cited by 73
“Importantly, many proinflammatory cytokines, including TNF, IL-1, IL-6, and IL-17, are important inducers of RANKL expression, as is prostaglandin E2 [28].”
Background
Functional Identification of Three Receptor Activator of NF-κB Cytoplasmic Motifs Mediating Osteoclast Differentiation and Function
Liu, W. X., Xu, D., Yang, H., Xu, H., Shi, Z., Cao, X., Takeshita, S., Liu, J., Teale, M., & Feng, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404687200 · Cited by 50
Self-citation
Raloxifene modulates interleukin-6 and tumor necrosis factor-alpha synthesis in vivo: results from a pilot clinical study.
Gianni, W., Ricci, A., Gazzaniga, P., Brama, M., Pietropaolo, M., Votano, S., Patané, F., Aglianó, A., Spera, G., Marigliano, V., et al. (2004) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2004-0795 · Cited by 55
Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis
Finzel, S., Kraus, S., Figueiredo, C., Regensburger, A., Kocijan, R., Rech, J., & Schett, G. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214894 · Cited by 54
RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis
Jhun, J., Lee, S. H., Kim, S. Y., Ryu, J., Kwon, J. Y., Na, H. S., Jung, K., Moon, S., Cho, M., & Min, J. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1809-3 · Cited by 65
SPHK1-S1PR1-RANKL Axis Regulates the Interactions Between Macrophages and BMSCs in Inflammatory Bone Loss
Xiao, L., Zhou, Y., Zhu, L., Yang, S., Huang, R. S., Shi, W., Peng, B., & Xiao, Y. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3396 · Cited by 66
“(14-17) M1 macrophage-derived cytokines either act directly on osteoclast precursors (via molecules such as TNF-α and IL-1β) to induce osteoclastogenesis or indirectly on osteoblasts (via molecules such as IL-6) or osteoblast precursors (known as BMSCs) to promote RANKL production.(18-24) Hence, the interaction betwee…”
Background
Psoriatic cutaneous inflammation promotes human monocyte differentiation into active osteoclasts, facilitating bone damage
Raimondo, A., Lembo, S., Caprio, R. D., Donnarumma, G., Monfrecola, G., Balato, N., Ayala, F., & Balato, A. (2017) · European Journal of Immunology · doi:10.1002/eji.201646774 · Cited by 54
Bone and TNF in rheumatoid arthritis: clinical implications
MANARA, M., & SINIGAGLIA, L. (2015) · RMD Open · doi:10.1136/rmdopen-2015-000065 · Cited by 56
Mechanisms of multiple myeloma bone disease
Galson, D. L., Silbermann, R. W., & Roodman, G. D. (2012) · BoneKEy Reports · doi:10.1038/bonekey.2012.135 · Cited by 50
Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: Subanalysis of the PREMIER study
Hoff, M., Kvien, T., Kälvesten, J., Elden, A., Kavanaugh, A., & Haugeberg, G. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-54 · Cited by 54
“Blocking of this receptor will down regulate the osteoclast formation [1,17].”
Background
Improvement of lumbar bone mass after infliximab therapy in Crohn's disease patients.
Mauro, M., Radovic, V., & Armstrong, D. (2007) · Canadian journal of gastroenterology = Journal canadien de gastroenterologie · doi:10.1155/2007/216162 · Cited by 54
“been shown in several in vitro studies (20-23).”
Substance P and its receptors in bone metabolism
Liu, D., Jiang, L., & Dai, L. (2007) · Neuropeptides · doi:10.1016/j.npep.2007.05.003 · Cited by 52
Pathophysiological roles for IL-18 in inflammatory arthritis
Matsui, K., Tsutsui, H., & Nakanishi, K. (2003) · Expert opinion on therapeutic targets · doi:10.1517/14728222.7.6.701 · Cited by 54
TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
Byström, J., Clanchy, F. I. L., Taher, T. E. I., Mangat, P. K., Jawad, A. S., Williams, R. O., & Mageed, R. A. (2016) · Cytokine · doi:10.1016/j.cyto.2016.09.001 · Cited by 58
“TNFa produced by T cells, as well as monocytes/macrophages, mediate pathology by initiating chronic inflammation, activating bone-resorbing osteoclasts and by inducing matrix metalloprotease production in inflamed joints [35,36].”
Gut microbiota and bone metabolism
Lu, L., Chen, X., Liu, Y., & Yu, X. (2021) · The FASEB Journal · doi:10.1096/fj.202100451r · Cited by 127
Systems-Level Analysis of Genome-Wide Association Data
Farber, C. R. (2013) · G3 Genes Genomes Genetics · doi:10.1534/g3.112.004788 · Cited by 51
T‐helper 17 cells mediate the osteo/odontoclastogenesis induced by excessive orthodontic forces
Hayashi, N., Yamaguchi, M., Nakajima, R., Utsunomiya, T., Yamamoto, H., & Kasai, K. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01886.x · Cited by 54
Bone Mineral Density and Serum Levels of Soluble Tumor Necrosis Factors, Estradiol, and Osteoprotegerin in Postmenopausal Women with Cirrhosis after Viral Hepatitis
Gonzalez-Calvin, J. L., Mundi, J. L., Casado-Caballero, F. J., Abadía, A. C., & Martin-Ibañez, J. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0835 · Cited by 54
Pro-Inflammatory Cytokines in Rheumatoid Arthritis: Pathogenetic and Therapeutic Aspects
Smolen, J. S., Redlich, K., Zwerina, J., Aletaha, D., Steiner, G. E., & Schett, G. A. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:3:239 · Cited by 77
Osteoclasts and Microgravity
Smith, J. K. (2020) · Life · doi:10.3390/life10090207 · Cited by 52
“TNF-α induces osteoclastogenesis in RANKL and M-CSF positive hematopoietic cell precursors [29, 30] where its effects are mediated by TNF-α receptors type 1 (p55r) and type 2 (p75r), the former being the most effective in inducing the differentiation of TRAP-positive multinucleated cells [31].”
Background
Osteoclast differentiation in rheumatoid arthritis
Yokota, K. (2023) · Immunological Medicine · doi:10.1080/25785826.2023.2220931 · Cited by 57
“In particular, proinflammatory cytokines, including TNF-a and IL-6, directly promote the differentiation of osteoclast precursors into multinucleated osteo-clasts [16,17].”
Background
An update on the role of RANKL–RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases
Brunetti, G., D’Amato, G., Chiarito, M., Tullo, A., Colaianni, G., Colucci, S. C., Grano, M., & Faienza, M. F. (2018) · World Journal of Pediatrics · doi:10.1007/s12519-018-0198-7 · Cited by 51
The impaired immune function and structural integrity by dietary iron deficiency or excess in gill of fish after infection with Flavobacterium columnare: Regulation of NF-κB, TOR, JNK, p38MAPK, Nrf2 and MLCK signalling
Guo, Y., Wu, P., Jiang, W., Liu, Y., Kuang, S., Jiang, J., Tang, L. Y., Tang, W., Zhang, Y., Zhou, X., et al. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.01.027 · Cited by 61
“Additionally, iron deficiency could increase human mesangial cell level of tumor necrosis factor α (TNF-α) [30], which could activate JNK in murine myeloid cells [31].”
Background
Plasmodium products persist in the bone marrow and promote chronic bone loss
Lee, M. S. J., Maruyama, K., Fujita, Y., Konishi, A., Lelliott, P. M., Itagaki, S., Horii, T., Lin, J., Khan, S. M., Kuroda, E., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aam8093 · Cited by 50
“These inflammatory cytokines robustly promote OC formation via OB RANKL induction (23, 24).”
Inhibition of KPNA4 attenuates prostate cancer metastasis
Yang, J., Lu, C., Wei, J., Guo, Y., Liu, W., Luo, L., Fisch, G., & Li, X. (2016) · Oncogene · doi:10.1038/onc.2016.440 · Cited by 57
Interleukin‐15‐activated natural killer cells kill autologous osteoclasts via LFA‐1, DNAM‐1 and TRAIL, and inhibit osteoclast‐mediated bone erosion in vitro
Feng, S., Madsen, S. H., Viller, N. N., Neutzsky-Wulff, A. V., Geisler, C., Karlsson, L., & Söderström, K. (2015) · Immunology · doi:10.1111/imm.12449 · Cited by 52
Role of Transforming Growth Factor-Beta (TGF) Beta in the Physiopathology of Rheumatoid Arthritis
Gonzalo-Gil, E., & Galindo-Izquierdo, M. (2014) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2014.01.006 · Cited by 52
Osteoclastogenesis is decreased by cysteine proteinase inhibitors
Brage, M., Lie, A., Ransjö, M., Kasprzykowski, F., Kasprzykowska, R., Abrahamson, M., GRUBB, A. O., & Lerner, U. H. (2004) · Bone · doi:10.1016/j.bone.2003.11.018 · Cited by 57
Wear particles and surface topographies are modulators of osteoclastogenesis in vitro.
Sommer, B., Felix, R., Sprecher, C., Leunig, M., Ganz, R., & Hofstetter, W. (2005) · Journal of Biomedical Materials Research. Part A · doi:10.1002/jbm.a.30202 · Cited by 52
“bone metabolism.(40) The data thus suggest that different cellular events take place in monocytes/macrophages exposed to small (sub- m) or large ( 10 m) wear particles.”
Background
Upregulated Cellular Expression of IL-17 by CD4+ T-Cells in Osteoporotic Postmenopausal Women
Zhao, R., Wang, X., & Feng, F. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000443531 · Cited by 51
Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: A possible mechanism for downregulation of osteoclastogenesis
Kamel Mohamed, S. G., Sugiyama, E., Shinoda, K., Hounoki, H., Taki, H., Maruyama, M., Miyahara, T., & Kobayashi, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.049 · Cited by 51
Multifactorial effects of hyperglycaemia, hyperinsulinemia and inflammation on bone remodelling in type 2 diabetes mellitus
Shahen, V. A., Gerbaix, M., Koeppenkastrop, S., Lim, S. F., McFarlane, K., Nguyen, A. N. L., Peng, X. Y., Weiss, N. B., & Brennan‐Speranza, T. C. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.04.001 · Cited by 53
Prevalence and risk factors associated with vertebral osteoporotic fractures in patients with rheumatoid arthritis
Tong, J., Xu, S., Zong, H.-X., Pan, M., Teng, Y., & Xu, J. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04787-9 · Cited by 60
“The pro-inflammatory cytokines TNF, IL-1, and IL-6 all enhance osteoclastogenesis and inhibit osteoblast function [11, 13].”
Background
Accelerated Aging in HIV Patients
Meir‐Shafrir, K., & Pollack, S. (2012) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10089 · Cited by 52
Tumor Necrosis Factor Receptor-associated Factor 6 Is an Intranuclear Transcriptional Coactivator in Osteoclasts
Bai, S., Zha, J., Zhao, H., Ross, F. P., & Teitelbaum, S. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802525200 · Cited by 41
Self-citation
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling
Rahman, M. M., Bhattacharya, A., & Fernandes, G. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600151-jlr200 · Cited by 88
Calcium sensing and cell signaling processes in the local regulation of osteoclastic bone resorption
Zaidi, M., Moonga, B. S., & Huang, C. L.-H. (2004) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1017/s1464793103006262 · Cited by 49
“TNFa itself also is important in bone, both acting synergistically with RANK-L (Azuma et al., 2000; Lam et al., 2000), and as a signal for osteoblast apoptosis (Hill, Tumber & Meikle, 1997).”
Background
Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosis
Zou, W., & Teitelbaum, S. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201410123 · Cited by 50
“Highexpressing BL21 (Stratagene) cells were lysed under nondenaturing conditions and GST-RANKL was purified over a glutathione-Sepharose column followed by ion exchange chromatography (Lam et al., 2000).”
Self-citation
IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis
Park, M. K., Her, Y., Cho, M. L., Oh, H.-J., Park, E., Kwok, S., Ju, J. H., Park, K. S., Min, D., Kim, H., et al. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.04.013 · Cited by 54
The therapeutic potential of costimulatory blockade with CTLA4Ig in rheumatoid arthritis
Emery, P. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.4.673 · Cited by 50
“TNF-α with RANKL acts directly to stimulate osteoclast differentiation of macrophages and myeloid progenitor cells [34], while IL-1 combined with RANKL is a major survival and activation signal for nascent osteoclasts [35].”
Background
The Autophagy in Osteoimmonology: Self-Eating, Maintenance, and Beyond
Xiao, L., & Xiao, Y. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00490 · Cited by 53
A Novel Receptor Activator of NF-κB (RANK) Cytoplasmic Motif Plays an Essential Role in Osteoclastogenesis by Committing Macrophages to the Osteoclast Lineage
Xu, D., Wang, S., Liu, J., Liu, J., & Feng, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510383200 · Cited by 41
A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL
Wang, H., Cawston, T. E., Richards, C. D., & Rowan, A. D. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1460 · Cited by 47
“Indeed, TNF-α stimulates differentiation of osteoclast precursors after priming by 31 ].”
TNF and bone.
David, J., & Schett, G. (2010) · Current directions in autoimmunity · doi:10.1159/000289202 · Cited by 49

Authors: Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L.
Affiliations: Washington University in St. Louis (US)
Barnes-Jewish Hospital (US)
Corresponding author: Teitelbaum, Steven L.
ORCID: Kanagawa, Osami
Teitelbaum, Steven L.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2000-12-15
Volume: 106
Issue: 12
Pages: 1481-1488
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci11176
PMC: PMC387259
OpenAlex: W2132933661
Cited by: 1,440
References: 0
Citations by year: 2026: 45 · 2025: 63 · 2024: 48 · 2023: 53 · 2022: 60 · 2021: 72 · 2020: 57 · 2019: 61 · 2018: 59 · 2017: 75 · 2016: 61 · 2015: 56 · 2014: 49 · 2013: 64 · 2012: 58
FWCI: 11.22
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
Funders: National Institutes of Health
National Institute of General Medical Sciences (T32GM007200)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK027726)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR-32788, AR-07033, R01AR032788, R37AR046523, T32AR007033, R01AR046852, AR46523, R01AR046523)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords: TNF-α, osteoclastogenesis, RANK ligand, macrophages, osteoclast precursors, NF-κB signaling, JNK signaling, inflammatory osteolysis, bone destruction, chimeric mice, cytokine synergy
MeSH terms: Animals, Carrier Proteins, Cell Differentiation, Cells, Cultured, Drug Synergism, Enzyme Activation, Flow Cytometry, Histocytochemistry, Macrophages, Membrane Glycoproteins, Osteoclasts, Stem Cells, Tumor Necrosis Factor-alpha, Bone Marrow Transplantation, NF-kappa B, Mitogen-Activated Protein Kinases, JNK Mitogen-Activated Protein Kinases, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks